Sou Hu Cai Jing·2026-01-14 08:42Group 1 - Elon Musk has made bold claims about the potential of AI robots, specifically the Optimus robot, to outperform top surgeons within three years, suggesting that studying medicine may become obsolete [1] - The medical community, represented by figures like Dr. Zhang Wenhong, has expressed skepticism about the feasibility of such predictions, highlighting the ongoing debate over the role of AI in healthcare [2] - Despite the uncertainty, the stock market has reacted positively to the AI healthcare sector, with companies like Hongbo Pharmaceutical and Dean Diagnostics seeing their stock prices double within five days, indicating strong investor interest [2] Group 2 - Major players in the tech industry are heavily investing in AI healthcare, with Nvidia committing $1 billion to AI drug development and OpenAI acquiring a medical data company to enhance healthcare data integration [2] - The competition for dominance in the AI healthcare space is likened to a race for essential resources, with data being referred to as the "water, electricity, and coal" of the new era [2] - The capital market tends to move faster than technological advancements, suggesting that investors are eager to capitalize on the potential of AI in healthcare, regardless of the eventual outcome [2]